Evidence map›Paper›PMID 31859619›Full record

ArticleJournal of medical microbiology2020

Eric D LoVullo, Herbert P Schweizer

Open access · greenAbstract read
In one paragraph

Article in Journal of medical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Modulation of themBio · 2025
    Article
  4. Functional interplay between RND efflux pumps and GacS inApplied and environmental microbiology · 2025
    Article
  5. Article
  6. Article
  7. 'Wild Type'.Microbiology (Reading, England) · 2024
    Review
  8. Article
  9. Inhibition ofAntimicrobial agents and chemotherapy · 2024
    Article
  10. Comparative molecular profiling of multidrug-resistantJAC-antimicrobial resistance · 2024
    Article
  11. Review
  12. Article
  13. Adaptation ofMicrobiology (Reading, England) · 2023
    Article
  14. Frequency of quorum-sensing mutations inMicrobiology (Reading, England) · 2022
    Article
  15. Article
  16. Frontiers in microbiology · 2022
    Review
  17. Microevolution of theFrontiers in microbiology · 2022
    Article
  18. Genomic characterization of carbapenem-non-susceptibleEmerging microbes & infections · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eric D LoVulloDepartment of Molecular Genetics and Microbiology, College of Medicine, Emerging Pathogens Institute, 2055 Mowry Road, Gainesville, FL 32610, USA.
Herbert P SchweizerDepartment of Molecular Genetics and Microbiology, College of Medicine, Emerging Pathogens Institute, 2055 Mowry Road, Gainesville, FL 32610, USA.

Funding

Combating resistant superbugs by understanding the molecular determinants of target site penetration and bindingR01AI136803 · NIAID · UNIVERSITY OF FLORIDA · PI BULITTA, JURGEN BERND · 2018 to 2022
$5.7M
NIAID NIH HHS R01 AI136803
6 · The paper itself

Abstract

Laboratory research with

Indexed as

Genetic VariationMutationSerial PassageBacterial ProteinsPseudomonas aeruginosaWhole Genome SequencingBacterial ProteinslineagesMexT diversityPseudomonas aeruginosastrain PAO1

Identifiers

PMID31859619
PMCPMC7363278
OpenAlexW2995656755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.